Shigeki Moriguchi Selected Research

Shigeki Moriguchi Research Topics

Disease

15	Alzheimer Disease (Alzheimer's Disease) 07/2022 - 10/2003
7	Ischemia 10/2009 - 09/2005
5	Brain Ischemia (Cerebral Ischemia) 10/2009 - 09/2005
4	Memory Disorders (Memory Loss) 01/2020 - 07/2008
3	Learning Disabilities (Learning Disability) 01/2018 - 04/2006
3	Dementia (Dementias) 01/2017 - 10/2003
3	Cognitive Dysfunction 01/2017 - 04/2011
3	Embolism (Embolus) 01/2008 - 09/2005
2	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2022 - 10/2013
2	Bipolar Disorder (Manic Depressive Psychosis) 10/2009 - 09/2006
2	Hypertrophy 01/2009 - 12/2007
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2008 - 10/2007
2	Infarction (Infarctions) 01/2008 - 01/2006
1	Anxiety Disorders (Anxiety Disorder) 01/2018
1	Autism Spectrum Disorder 10/2016
1	Inflammation (Inflammations) 10/2016
1	Neoplasms (Cancer) 03/2015
1	Autistic Disorder (Autism) 01/2014
1	X-Linked Mental Retardation (Mental Retardation, X Linked) 06/2011
1	ATR-X syndrome 06/2011
1	Thalassemia 06/2011
1	Schizophrenia (Dementia Praecox) 10/2009
1	Mental Disorders (Mental Disorder) 10/2009
1	Myocardial Infarction 01/2008
1	Reperfusion Injury 10/2007
1	Rhabdomyosarcoma 09/2007
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 07/2006

Drug/Important Bio-Agent (IBA)

10	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2020 - 04/2006
6	Cholinergic Agents (Cholinergics)IBA 03/2014 - 10/2003
5	Proteins (Proteins, Gene)FDA Link 05/2018 - 09/2005
5	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2017 - 12/2003
4	Nootropic Agents (Nootropics)IBA 10/2013 - 10/2003
3	N-Methylaspartate (NMDA)IBA 10/2009 - 10/2005
3	Tyrosine (L-Tyrosine)FDA Link 01/2008 - 09/2005
3	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2008 - 09/2006
3	CalcineurinIBA 12/2007 - 07/2006
3	3- (2- (4- (3- chloro- 2- methylphenyl)1- piperazinyl)ethyl)5,6- dimethoxy- 1- (4- imidazolylmethyl)- 1H- indazol dihydrochloride 3.5 hydrateIBA 12/2007 - 09/2005
2	Donepezil (Aricept)FDA LinkGeneric 01/2017 - 10/2005
2	Pyrrolidinones (Pyrrolidones)IBA 10/2013 - 10/2003
2	spiro(imidazo- (1,2- a)pyridine- 3,2- indan)- 2(3H)- oneIBA 04/2011 - 07/2008
2	Calcium-Calmodulin-Dependent Protein KinasesIBA 10/2009 - 09/2006
2	3- (2- (4- (3- chloro- 2- methylphenyl)- 1- piperazinyl)ethyl)- 5,6- dimethoxyindazoleIBA 01/2009 - 12/2007
2	Fas Ligand Protein (Fas Ligand)IBA 10/2007 - 09/2007
2	CalpainIBA 09/2007 - 07/2006
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 02/2007 - 10/2005
2	nefiracetamIBA 12/2003 - 10/2003
1	Propolis (Bee Bread)IBA 07/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020
1	protein kinase modulatorIBA 01/2020
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 01/2020
1	KN 93IBA 01/2020
1	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	zeta-inhibitory peptideIBA 01/2020
1	U 0126 (UO 126)IBA 01/2020
1	Messenger RNA (mRNA)IBA 05/2018
1	CalciumIBA 05/2018
1	CorticosteroneIBA 01/2018
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2017
1	Memantine (Namenda)FDA Link 01/2017
1	GTP-Binding Proteins (G-Protein)IBA 10/2016
1	LigandsIBA 10/2016
1	Protein Kinases (Protein Kinase)IBA 10/2016
1	Rivastigmine (Exelon)FDA LinkGeneric 03/2014
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2014
1	MelatoninIBA 01/2014
1	Piracetam (Nootropil)IBA 10/2013
1	DM 235IBA 10/2013
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 02/2012
1	Sigma-1 ReceptorIBA 06/2011
1	Dehydroepiandrosterone (DHEA)IBA 06/2011
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 06/2011
1	Adenosine Triphosphate (ATP)IBA 06/2011
1	Protein Kinase CIBA 06/2011
1	nobiletinIBA 10/2009
1	Antipsychotic Agents (Antipsychotics)IBA 10/2009
1	Serotonin (5 Hydroxytryptamine)IBA 10/2009
1	CytokinesIBA 10/2009
1	Nerve Growth Factors (Neurotrophins)IBA 10/2009
1	Dopamine (Intropin)FDA LinkGeneric 10/2009
1	ErbB Receptors (EGF Receptor)IBA 10/2009
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 10/2009
1	indanIBA 07/2008
1	pyridineIBA 07/2008
1	Glutamic Acid (Glutamate)FDA Link 01/2008
1	CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA 01/2008
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2008
1	vanadyl sulfateIBA 01/2008
1	DystrophinIBA 12/2007
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 12/2007
1	Angiotensin IIIBA 12/2007
1	Endothelin-1 (Endothelin 1)IBA 12/2007
1	phospholambanIBA 12/2007
1	Tacrolimus (Prograf)FDA LinkGeneric 09/2007
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 09/2007
1	LithiumIBA 09/2006

Therapy/Procedure

3	Therapeutics 04/2011 - 09/2006
3	Microspheres (Microsphere) 01/2008 - 09/2005
1	Aftercare (After-Treatment) 03/2015
1	Oral Administration 07/2008